recombinant human CFH protein (Optherion)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant human CFH protein (Optherion)
Drug Alias Namerecombinant human complement factor H protein (Optherion)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement factor H modulators
TargetsComplement factor H
Therapy Area/IndicationsKidney DiseasesMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOptherion Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOptherion Inc
Active IndicationsN/A
Inactive IndicationsKidney DiseasesMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A